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Abstract
By using a strategy that we have developed to search for the ligands of orphan seven-transmembrane-domain receptors
[S. Hinuma et al., Nature 393 (1998) 272^276], we have recently identified a natural ligand, apelin, for the orphan 7TMR,
APJ [K. Tatemoto et al., Biochem. Biophys. Res. Commun. 251 (1998) 471^476]. In this paper, we isolated rat and mouse
apelin cDNAs, and analyzed the tissue distribution of apelin mRNA in rats. Although apelin mRNA was widely detected in
a variety of tissues, the highest expression of apelin mRNA was detected in the mammary gland of pregnant rats. In the
mammary gland, biologically active apelin and its mRNA considerably increased during pregnancy and lactation, and
reached a maximal level around parturition. Moreover, a large amount of apelin (14^93 pmol/ml) was found to be secreted in
the bovine colostrum, and it was still detectable even in commercial bovine milk. Since apelin partially suppressed cytokine
production by mouse spleen cells in response to T cell receptor/CD3 cross-linking, the oral intake of apelin in the colostrum
and milk might modulate immune responses in neonates. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Various sorts of biologically active molecules, in-
cluding hormones, neurotransmitters, and chemo-
kines, transmit signals into cells by binding to so-
called seven-transmembrane-domain receptors
(7TMRs). Since these receptors are coupled to gua-
nine nucleotide-binding protein (G protein) to trans-
duce intracellular signals, they are also called G pro-
tein-coupled receptors [3,4]. Recent progress in both
cDNA and genome DNA analyses has led to the
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reverse transcription; PCR, polymerase chain reaction; RACE,
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discovery of numerous 7TMR-like genes. Since most
of their endogenous ligands are unidenti¢ed, they are
referred to as ‘orphan’ 7TMRs [5]. We have recently
developed a strategy to identify the ligands of orphan
7TMRs by monitoring the speci¢c signal transduc-
tions induced in Chinese hamster ovary (CHO) cells
expressing orphan 7TMRs [1,2]. Employing this
method, we ¢rst succeeded in identifying the natural
ligand of the orphan 7TMR, hGR3. The peptidic
ligand identi¢ed for hGR3 was found to show a spe-
ci¢c prolactin-release-promoting activity, and so was
named prolactin-releasing peptide [1].
We subsequently searched for the natural ligand of
another orphan 7TMR, APJ, which was originally
isolated from human genomic DNA [6]. APJ encodes
a protein slightly resembling the angiotensin II recep-
tor, having about 30% amino acid sequence identity
overall. However, angiotensin II did not interact with
APJ when expressed in ¢broblasts [6] and CHO cells
[2]. In order to detect the speci¢c signal transduction
in CHO cells expressing APJ, we utilized a Cytosen-
sor which could measure extracellular acidi¢cation
induced by the interaction of ligands and receptors
[7]. We found that peptide-enriched fractions pre-
pared from bovine stomach tissue extracts showed
a speci¢c activity to promote the acidi¢cation rate
in CHO cells expressing APJ [2]. By monitoring
this activity, we puri¢ed a ligand peptide for APJ
from this extract. We subsequently isolated human
and bovine cDNAs based on the sequence of the
puri¢ed peptide. These cDNAs encoded prepropro-
teins consisting of 77 amino acid residues. Since the
puri¢ed peptide sequence was situated in their C-ter-
minal portions, we predicted that a peptide of 36
amino acid in length, including almost all of the C-
terminal portion, would comprise a mature form.
When synthesized, this peptide showed a speci¢c
acidi¢cation-rate-promoting activity to CHO cells ex-
pressing APJ. We named it apelin after APJ endog-
enous ligand [2].
Although CXCR4 and CCR5 are thought to func-
tion as main coreceptors with CD4 in the process of
human immunode¢ciency virus (HIV) type 1 infec-
tion [8], APJ has recently been reported to be one of
several alternative coreceptor candidates [9^12].
Although APJ does not show high overall homology
with chemokine receptors, including CCR5, CCR3,
and CXCR4, APJ shows sequence similarity to these
chemokine receptors in the N-terminal region, which
is con¢rmed to be very important for the interaction
with HIV [9]. It is thus a very interesting question
whether or not apelin might in£uence HIV infection
via APJ.
In this paper, we isolated rat and mouse apelin
cDNAs, and then analyzed the precise tissue distri-
bution of rat apelin mRNA by quantitative reverse
transcription-polymerase chain reaction (RT-PCR).
Apelin mRNA was widely distributed in rat tissues,
and most highly expressed in the mammary gland
during pregnancy and lactation. We will subse-
quently demonstrate here the secretion of large
amounts of apelin peptides into the colostrum and
milk, and discuss the physiological signi¢cance of
these ¢ndings.
2. Materials and methods
2.1. Cloning of mouse and rat apelin cDNAs
We isolated mouse and rat apelin cDNAs from the
poly(A) RNA fractions prepared from mouse and
rat brain, respectively, by the 3P and 5P rapid am-
pli¢cation of cDNA ends (RACE) method using a
Marathon cDNA ampli¢cation kit (Clontech, Palo
Alto, CA, USA) in a manner similar to that used
previously for the cloning of human and bovine ape-
lin cDNAs [2]. We designed primers, 5P-CTGGC-
AGGGAGGCAGGAGGAA-3P and 5P-GCAGGA-
GGAAATTTCGCAGACAGC-3P for 3P RACE,
and 5P-GAAGAGAATTCATCTGTGGAGTA-3P
and 5P-ACCGGCACCGGGAGGGCACTT-3P for
5P RACE. PCR was carried out in combination
with the adapter primers provided with the kit. The
¢rst set of PCR reactions for RACE were carried out
under the following conditions: 94‡C for 2 min;
5 cycles of 98‡C for 10 s and 72‡C for 2 min; 5 cycles
of 98‡C for 10 s and 70‡C for 2 min; 25 cycles of
98‡C for 10 s and 68‡C for 2 min. The resultant PCR
products were then used as the templates for the
second set of nested PCR under the conditions:
94‡C for 2 min; 5 cycles of 98‡C for 10 s and 72‡C
for 2 min; 5 cycles of 98‡C for 10 s and 70‡C
for 2 min; 30 cycles of 98‡C for 10 s and 68‡C for
BBAMCR 14539 5-10-99
Y. Habata et al. / Biochimica et Biophysica Acta 1452 (1999) 25^3526
2 min. DNA sequences thereby obtained were ana-
lyzed with a DNA sequencer (model 377, ABI,
Foster City, CA, USA), and entire mouse and rat
apelin cDNA sequences stretching 234 bp in total
were determined respectively on the basis of these
sequences.
2.2. Quantitative analyses for rat apelin mRNA by
RT-PCR
Poly(A) RNAs were prepared from the tissues of
8-week-old male or female Wistar rats (Japan SLC,
Shizuoka, Japan). The mammary glands obtained
from three female rats in various reproductive stages
were pooled and then their poly(A) RNA fractions
were prepared using Isogen (Nippon Gene, Toyama,
Japan) followed by an mRNA Puri¢cation Kit
(Pharmacia, Uppsala, Sweden). Complement DNAs
were synthesized from poly(A) RNAs (160 ng)
treated with deoxyribonuclease I (ampli¢cation
grade, Gibco BRL, Grand Island, NY) in the pres-
ence of 2.5 WM of random 9-mer nucleotides (Takara
Shuzo, Kyoto, Japan), and 10 units of AMV reverse
transcriptase XL (Life Sciences, Petersburg, FL,
USA) at 42‡C for 30 min. We quanti¢ed rat apelin
mRNA by means of a Prism 7700 Sequence Detector
(ABI) [13,14] with a primer set (5P-GGCTAGAA-
GAAGGCAACATGC-3P, 5P-CCGCTGTCTGCGA-
AATTTC-3P) and a hybridization probe labeled with
£uorescent dyes (5P(FAM)-TGGTGAAGCCCAGA-
ACTTCGAGGA-(TAMRA)3P). PCR was carried
out in a 25-Wl reaction mixture prepared with a Taq-
Man PCR Core Reagent Kit (ABI) containing an
appropriately diluted cDNA solution, 1 WM of each
primer, and 200 nM probe. PCR was conducted
under the following conditions: 50‡C for 2 min for
the reaction of uracil N-glycosylase to prevent the re-
ampli¢cation of PCR products carried over; 95‡C
for 10 min for the activation of AmplyTaq Gold
DNA polymerase; and 45 cycles of 95‡C for 15 s
and 57‡C for 80 s for ampli¢cation. In order to ob-
tain a calibration curve, we ampli¢ed a known
amount of a plasmid encompassing rat apelin
cDNA in the same manner as the samples. A good
linear relationship was obtained between the amount
of rat apelin cDNA input and the release of the
reporter dye within the range of 10^106 copies. Rat
glyceraldehyde 3-phosphate dehydrogenase (G3-
PDH) mRNA was also measured as an internal con-
trol using Rodent G3PDH Control Reagents (ABI)
according to the manufacturer’s instruction, in the
same manner as used for the quanti¢cation of rat
apelin cDNA. The contents of G3PDH mRNA in
the poly(A) RNA fractions obtained from the rats
tended to decrease along with the progress of preg-
nancy and lactation (data not shown).
2.3. Synthesis of apelin peptides
[pGlu]Apelin-13 (pERPRLSHKGPMPF), apelin-
13 (QRPRLSHKGPMPF), apelin-17 (KFRRQRP-
RLSHKGPMPF), and apelin-36 (LVQPRGPRSG-
PGPWQGGRRKFRRQRPRLSHKGPMPF) were
synthesized using an automatic peptide synthesizer
(Model 430, ABI) as described previously [2].
2.4. Assay for inhibition of cAMP production by
apelin
CHO cells with introduced human APJ cDNA
were established as described previously [2]. The in-
hibitory activity of apelin to cAMP production by
these cells was measured in the presence of 0.2 mM
3-isobutyl-1-methylxanthine (IBMX, Sigma, St.
Louis, MO, USA) and 1 WM forskolin (Wako, Osa-
ka, Japan) in an in vitro culture, and the amount of
cAMP was determined with a cAMP enzyme immu-
noassay (EIA) system (Amersham, Buckinghamshire,
UK) as described elsewhere [15]. As a control, we
used CHO dhfr3 cells, a parent cell line, prior to
transfecting the expression vector plasmid containing
human APJ cDNA, in order to assess non-speci¢c
activities in the samples.
2.5. Quanti¢cation of apelin based on
cAMP-production-inhibitory activity
In order to determine the content of apelin, we
obtained tissues from female Wistar rats (8 weeks
old) immediately after decapitation. They were
pooled (about 1.5^5 g), if necessary, and then kept
on ice until used for the quanti¢cation. Each tissue
was boiled in 20 ml of water for 15 min, supple-
mented with up to 1 M acetic acid, and homogenized
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using a Polytron homogenizer. The supernatant pre-
pared by centrifugation was supplemented with up to
0.1% tri£uoroacetic acid (TFA), and then applied to
a Sep-Pak Vac C18 20 cc column (5 g, Waters, Mil-
ford, MA, USA). Elution was performed in stepwise
increments of 10%, 30%, and 50% CH3CN in 0.1%
TFA in water. The 30% CH3CN fraction was further
fractionated by HiTrap CM-Sepharose FF 5 ml
(Pharmacia) in stepwise increments of 0.1, 0.2, and
1 M CH3COONH4 (pH 6.4) containing 10%
CH3CN. The 1 M CH3COONH4 fraction desalted
using a Sep-Pak plus C18 cartridge (Waters) was
lyophilized, and then applied to the cAMP-produc-
tion-inhibitory assay using CHO cells expressing hu-
man APJ.
Colostrum and milk from Holstein cows (3^5
years old) were kindly supplied by Hinode Rakunou
(Tsukuba, Japan). Pasteurized bovine milk was pur-
chased at markets in Tsukuba. Rat milk was col-
lected and pooled from ¢ve Wistar rats after partu-
rition. In order to determine the content of apelin,
milk was boiled for 15 min, an equal volume of 1 M
acetic acid added, and homogenized by a Polytron
homogenizer. After centrifugation, the resultant
supernatant was fractionated in the same manner
as the rat tissues, and then subjected to the cAMP-
production-inhibitory assay. The amounts of apelin
in the tissue and milk extracts were quanti¢ed on the
basis of a calibration curve obtained using synthetic
[pGlu]apelin-13.
2.6. Analyses for e¡ects of apelin on cytokine
production
Spleens were aseptically removed from female
BALB/c mice (8 weeks old, Charles River Japan,
Atsugi, Japan), and single cell suspensions were pre-
pared by gently squeezing the spleen between two
glass slides in Hanks’ balanced salt solution supple-
mented with HEPES, 5 U/ml of heparin, and 5%
NuSerum (Becton Dickinson Labware, Bedford,
MA, USA). The cells were suspended in RPMI
1640 medium supplemented with HEPES, L-glut-
amine, penicillin G, streptomycin, 2-mercaptoethanol,
and 10% NuSerum, and cultured at 2.5U106 cells/ml
in 96-well £at-bottomed microplates (Nippon In-
terMed, Tokyo, Japan) pre-coated with 2 Wg/ml of
anti-CD3 monoclonal antibodies (mAbs) (145-2C11,
Cedarlane Laboratories, Ontario, Canada) in the
presence or absence of apelin peptides. After cultur-
ing for 24 h, the supernatants were harvested to
measure the cytokines produced.
The concentrations of interleukin-2 (IL-2), inter-
leukin-4 (IL-4), and interferon-Q (IFN-Q) were deter-
mined by sandwich EIA. The capture antibodies used
were rat anti-mouse IL-2 mAbs (Genzyme, Cam-
bridge, MA, USA), rat anti-murine IL-4 mAbs
(clone BVD4-1D11, Endogen, Cambridge, MA,
USA), and hamster anti-murine IFN-Q mAbs (Gen-
zyme). Detection antibodies used were rabbit anti-
mouse IL-2 polyclonal antibodies (Becton Dickin-
son), rat anti-murine IL-4 mAbs (clone BVD6-
24G2, Endogen), and rat anti-mouse IFN-Q mAbs
(clone XMG1, 2, Upstate Biotechnology, Lake Plac-
id, NY, USA). The 96-well microplates were coated
with 100 Wl of the capture antibodies (2 Wg/ml) di-
luted with borate bu¡er (BB) at pH 8.5. After over-
night incubation at room temperature, the wells were
blocked with 1% BSA in BB for 30 min at room
temperature. The wells were washed three times
with BB containing 0.05% Tween 20, and then the
culture supernatants were incubated for 90 min at
room temperature. After the wells were washed
with BB containing 0.05% Tween 20, the detection
antibodies corresponding to the capture antibodies
were appropriately diluted and added to the wells.
After incubation for 90 min, the wells were washed
with BB containing 0.05% Tween 20, and peroxidase-
conjugated monoclonal mouse anti-rat IgG1 (Exper-
imental Immunology, Belgium) or peroxidase-conju-
gated monoclonal rat anti-rabbit IgG (Zymed Labo-
ratories, San Francisco, CA, USA) antibodies were
added to the wells, respectively. The wells were then
incubated for 90 min, washed with BB containing
0.05% Tween 20, and supplemented with o-phenyl-
enediamine (1 mg/ml) in phosphate bu¡er at pH 7
containing 0.2 Wl/ml of H2O2. After a ¢nal incuba-
tion for 40 min, the colorimetric reaction was
stopped with 1.5 N H2SO4. Absorbance at 492 nm
minus that at 630 nm was measured by a MTP-32
microplate reader (Corona Electric, Ibaraki, Japan).
The concentrations of cytokines in the culture super-
natants were determined on the basis of calibration
curves obtained using standard cytokines. As stand-
ard cytokines, we used recombinant mouse IL-2, IL-
4, and IFN-Q (Genzyme).
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3. Results
3.1. Cloning of cDNAs encoding mouse and rat apelin
preproproteins
Based on the sequence of a mouse expressed se-
quence tag (EST) in the GenBank/EMBL database
(accession number W33327), which possessed signi¢-
cant homology to the bovine apelin sequence [2], we
isolated the mouse and rat cDNAs from the poly-
(A) RNA fractions prepared from mouse and rat
brain, respectively, by means of RACE. The amino
acid sequences encoded by bovine, human, rat and
mouse cDNAs are aligned in Fig. 1. These cDNAs
encoded preproproteins of 77 amino acid residues in
length. Their N-terminal portions, comprising 22
amino acid residues, were rich in hydrophobic amino
acid residues, and showed a typical pro¢le of secre-
tory signal sequences. Since it has been proven that
endogenous mature apelin peptide puri¢ed from bo-
vine stomach tissue extracts starts at Leu-42 and in-
cludes almost all of the C-terminal portion [2], sim-
ilar endogenous apelin peptides were expected to
exist in mice and rats. In comparing these sequences,
the C-terminal portion from positions Trp-55 to Phe-
77 was absolutely conserved among the four species
tested.
3.2. Tissue distribution of rat apelin mRNA
We quantitatively analyzed the distribution of ape-
lin mRNA in rat tissues by RT-PCR, and detected
apelin mRNA in various tissues tested. In the periph-
eral tissues, we detected a very high level of apelin
mRNA in the lung; moderate levels of apelin mRNA
in the heart, adipose tissue, testis, and ovary (data
not shown). Interestingly, we detected the highest
level of apelin mRNA in the mammary gland of
the lactating rats. We therefore determined the
change of apelin mRNA expression levels in the
mammary gland during pregnancy and lactation in
rats. We repeated several similar experiments, and
show a representative result in Fig. 2. Although the
expression of apelin mRNA was not particularly
high in control virgin rats, it gradually increased in
accordance with the development of the mammary
gland during pregnancy, and reached a maximal level
around parturition. High levels of apelin mRNA
were consistently detected during lactation.
3.3. Inhibition of cAMP production in CHO cells
expressing human APJ by apelin
Since the C-terminal portion of preproapelin con-
tains a number of basic amino acid residues which
Fig. 1. Amino acid sequences of bovine, human, rat, and mouse apelin preproproteins. Amino acid residues identical in at least two
species are boxed. The ¢lled arrowhead indicates the predicted cleavage site of secretory signal peptides. The open arrowhead indicates
the N-terminus of apelin-36, which was originally identi¢ed as an endogenous apelin in the bovine stomach tissue extracts. The nu-
cleotide sequence data of apelin cDNAs will appear in the DDBJ/EMBL/GenBank databases with the accession numbers AB023492,
AB023493, AB023494, and AB023495, respectively.
BBAMCR 14539 5-10-99
Y. Habata et al. / Biochimica et Biophysica Acta 1452 (1999) 25^35 29
are potential cleavage sites by peptidases, it is ex-
pected that various sizes of apelin would exist as
endogenous ligands. We hence synthesized various
length of apelin peptides including apelin-17, ape-
lin-13, and [pGlu]apelin-13. [pGlu]Apelin-13 was
synthesized as a pyroglutaminated form of apelin-
13, because Glu at the N-terminus of bioactive pep-
tides is frequently pyroglutaminated in vivo through
processing [16^20]. As shown in Fig. 3, forskolin-
stimulated cAMP production in CHO cells express-
ing human APJ was inhibited by the addition of
[pGlu]apelin-13, apelin-13, apelin-17, and apelin-36
in a dose-dependent fashion, with IC50 values of
0.17, 0.16, 0.28, and 0.52 nM, respectively. By the
higher concentrations of these apelin peptides, the
forskolin-stimulated cAMP production was sup-
pressed to nearly the basal level. However, they
showed no signi¢cant inhibition of the forskolin-
stimulated cAMP production in CHO dhfr3 cells, a
parent cell line of CHO cells which does not express
human APJ, even at 1037 M, indicating that the in-
hibition of cAMP production was induced in CHO
cells by the speci¢c interaction between APJ and
apelin.
3.4. The distribution of biologically active apelin in rat
tissues
We quanti¢ed the contents of bioactive apelin in
rat tissues based on the speci¢c inhibitory activity to
the forskolin-stimulated cAMP production in CHO
cells expressing human APJ. We repeated several
similar experiments, and show a representative result
in Fig. 4A. Among the tissues examined, a high con-
tent of apelin was detected only in the lung, while
moderate levels of apelin were detected in the heart,
ovary, and brain. A small amount of apelin was also
detected in the adipose tissue.Fig. 2. Increased expression of rat apelin mRNA in the mam-
mary gland during pregnancy and lactation. Mammary glands
obtained from three female rats during pregnancy (indicated
days after copulation) and lactation (indicated days after partu-
rition) and control virgin rats were pooled respectively, and
then their poly(A) RNA preparations were subjected to quan-
titative RT-PCR analyses using a Prism 7700 Sequence Detec-
tor. Parturition was observed between day 21 of pregnancy and
day 0 of lactation. The amounts of apelin mRNA were deter-
mined in quadruplicate assays per sample. Values represents
mean þ S.E.M.
Fig. 3. Inhibition of forskolin-stimulated cAMP production in
CHO-A10 cells by apelin. The e¡ects of [pGlu]apelin-13 (b,a),
apelin-13 (R,O), apelin-17 (F,E), and apelin-36 (S,P) at the
indicated concentrations added to CHO cells expressing human
APJ or CHO dhfr3 cells respectively, and cAMP production
were examined in the presence of 0.2 mM IBMX and 1 WM
forskolin. The inhibition of the cAMP production is indicated
as percentage of inhibition against maximum cAMP production
by CHO cells without apelin. Values represent mean þ S.E.M.
in triplicate assays.
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In the mammary gland, we detected larger
amounts of apelin than in the other tissues. In ac-
cordance with the increase of apelin mRNA (Fig. 2),
the content of bioactive apelin also increased as preg-
nancy progressed (Fig. 4B). The content of apelin
gradually increased during pregnancy and reached
a peak around parturition. Then it gradually de-
creased to the basal level during the lactating period.
The kinetics of the apelin increment appeared to par-
allel those of apelin mRNA during pregnancy. How-
ever, although the expression of apelin mRNA was
sustained at the higher level during the lactating pe-
riod, apelin decreased to the basal level at 21 days
after parturition.
3.5. Secretion of apelin in colostrum and milk
Based on the results that apelin and its mRNA
were highly expressed in the mammary gland during
pregnancy and lactation, we expected that apelin
would be secreted in milk from the mammary gland.
Accordingly, we performed the cAMP-production-
inhibitory assay and detected a high concentration
of apelin (45.8 pmol/ml) in rat milk collected from
Fig. 4. Distribution of apelin in rat tissues. The contents of apelin in the indicated tissues were determined on the inhibitory activities
of their extracts to forskolin-stimulated cAMP production in CHO cells expressing human APJ. A calibration curve to quantify the
contents of apelin was obtained using synthetic [pGlu]apelin-13. (A) The contents of apelin in the rat tissues. (B) The contents of ape-
lin in the mammary gland during pregnancy and lactation. Mammary glands obtained from female rats during pregnancy (indicated
days after copulation) and lactation (indicated days after parturition) and control virgin rats were pooled respectively, and then sub-
jected to the assay. The tissues were prepared at the same time as the experiments of Fig. 2.
Fig. 5. Contents of apelin in bovine colostrum and milk. The contents of apelin were quanti¢ed on the basis of the cAMP-produc-
tion-inhibitory activities in a manner similar to that described in Fig. 4. Bovine colostrum and milk were obtained from three Holstein
cows (No. 1^3) on the indicated days after parturition.
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day 1 to 14 after parturition (data not shown). In
addition, we detected apelin in commercially avail-
able bovine milk, at a concentration ranging from
0.6 to 1.2 pmol/ml in several di¡erent lots (data
not shown).
We subsequently examined the change of apelin
content in bovine milk during the lactating period
(Fig. 5). For this time course study, we obtained
colostrum and milk samples from three Holstein
cows 0^11 days after parturition. Although the con-
tent of apelin in the colostrum and milk varied con-
siderably among the cows examined, we detected
higher levels of apelin in the colostrum than in the
milk in all cows, and the apelin content drastically
decreased within several days after parturition.
3.6. Modulation of cytokine productions by apelin
Since many components capable of modulating
immune responses are secreted in milk [21], we exam-
ined whether or not apelin has such activities. In Fig.
6, as a representative result of several experiments,
both apelin-36 and [pGlu]apelin-13 partially sup-
pressed IFN-Q, IL-2, and IL-4 productions from
BALB/c mouse spleen cells stimulated with immobi-
lized anti-CD3 mAbs in an in vitro culture. However,
[pGlu]apelin-13 was more potent in this activity than
apelin-36, which seemed to parallel the results of the
cAMP-production-inhibitory assay. We observed
that the proliferation of mouse spleen cells in re-
sponse to CD3 cross-linking was also partially sup-
pressed by these peptides (data not shown). These
results suggest that apelin plays a role in regulating
immune responses.
4. Discussion
Based on the information of mouse EST in the
database, we isolated apelin cDNA from rat and
mouse brains. Bovine, human, rat, and mouse apelin
cDNAs encoded preproproteins of the same length
of 77 amino acids. When the amino acid sequences of
apelin preproproteins were compared among these
species, their amino acid identity ranged from 76%
to 95%. The amino acid sequences of a mature apelin
peptide (e.g., apelin-36) appeared to be more con-
served among the species (i.e., 86^100% amino acid
identity). In particular, their C-terminal regions from
Trp-55 to Phe-77, a segment of 23 amino acid resi-
dues in length, were completely conserved among the
species, suggesting that the C-terminal region is func-
tionally important in apelin. Indeed, since apelin-13,
[pGlu]apelin-13, and apelin-17 showed a stronger
cAMP-production-inhibitory activity to CHO cells
expressing human APJ than apelin-36, it is unequiv-
ocal that a core structure essential for the interaction
between apelin and APJ is localized at the C-terminal
region of apelin.
We synthesized [pGlu]apelin-13 as a pyroglutamin-
Fig. 6. Suppression of cytokine production in mouse spleen cells by apelin. Spleen cells obtained from BALB/c were cultured in micro-
plates coated with anti-CD3 mAbs in the presence or absence (control) of apelin-36 (closed columns) and [pGlu]apelin-13 (open col-
umns) at the indicated concentrations. The amounts of IFN-Q (panel A), IL-2 (panel B), and IL-4 (panel C) in culture supernatants
were determined by EIA. Values represent mean þ S.D. in triplicate assays. **P6 0.01; *P6 0.05, as compared with a control in Stu-
dent’s t-test.
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ated form of apelin-13, and the two peptides were
equipotent in both the acidi¢cation-rate-promoting
and cAMP-production-inhibitory assays. Since
[pGlu]apelin-13 is structurally more stable than ape-
lin-13, we mainly used [pGlu]apelin-13 in this study.
In these two assays, di¡erences among the potency of
the apelin peptides appeared to be greater in the
acidi¢cation-rate-promoting assay than in the
cAMP-production-inhibitory assay [2]. The former
assay principally detects proton excretion as a total
output of cellular events. On the other hand, the
latter detects the change of the intracellular second
messenger, cAMP. As the extracellular proton excre-
tion is an event downstream in a cascade of the intra-
cellular changes, the ampli¢ed di¡erences among the
apelin peptides might be more readily detected in the
acidi¢cation-rate-promoting assay. With respect to
the signal transduction pathway of APJ, we could
not detect Ca2 mobilization or the release of arach-
idonic acid metabolites in CHO cells expressing hu-
man APJ after the addition of [pGlu]apelin-13 and
apelin-36 (data not shown). These results suggest
that APJ is coupled to Gi but not to Gs or Gq.
Among the rat tissues tested, the mammary gland
of lactating rats showed the highest expression of
apelin and its mRNA. Prior to pregnancy, the ex-
pression levels of apelin and its mRNA in female
rats were not particularly high, but they gradually
increased in parallel with the development of the
mammary gland during pregnancy, and reached a
maximum level around late pregnancy and parturi-
tion. Even after parturition, high levels of apelin and
its mRNA were still detected in the mammary gland.
We therefore expected that apelin would be secreted
in milk. Indeed, apelin was detected in not only bo-
vine and rat milk, but also human milk. In our pre-
liminary experiments, about 0.2 pmol/ml of apelin
was detected in human milk (data not shown). In
the time course study using bovine milk, the highest
level of apelin content was detected in the colostrum,
and it rapidly decreased within several days after
parturition. A certain level of apelin is likely to exist
consistently in bovine milk during lactation, because
we could detect apelin in commercially available bo-
vine milk. Our results demonstrated that apelin pro-
duced in the mammary gland was actually secreted in
the colostrum and milk.
Based on the following results of our previous
study [2], we expected that endogenous apelin would
have multiple isoforms: (1) the chromatographic be-
havior of apelin extracted from the bovine stomach
was heterogeneous; (2) in the bovine apelin prepro-
protein sequence, downstream of the secretory signal
sequence with 22 amino acid residues, there were
many arginine and lysine residues (i.e., Lys-32, 61,
and 72, and Arg-40, 46, 49, 59, 60, 63, 64, 66, and
68) which are potential proteolytic cleavage sites; (3)
synthetic apelin peptides shorter than apelin-36 (e.g.,
apelin-17, apelin-13, and [pGlu]apelin-13) showed
evident activities to interact with APJ. Since apelin
was found to be abundantly secreted in milk, we
analyzed the molecular heterogeneity of endogenous
apelin in milk. By the puri¢cation of apelin from
bovine milk, we found that at least three di¡erent
apelin isoforms, starting at the N-terminal amino
acid residues, Leu-42, Gly-47, and Ser-50, respec-
tively, existed in the milk (data not shown). In the
Western blot analyses using rabbit polyclonal anti-
body obtained by immunizing apelin-17 conjugated
with thyroglobulin, we found that there were at least
¢ve apelin isoforms having di¡erent molecular
weights in the bovine colostrum (data not shown).
Although we have not been able to directly demon-
strate the existence of apelin-13 as an endogenous
ligand, we observed that apelin-13 was actually pro-
duced when apelin cDNA was expressed in CHO
cells (data not shown). These observations appear
to support the idea that endogenous apelin is very
heterogeneous.
Milk is not only a rich source of nutrients, but it is
also known to contain a variety of biologically active
substances, including peptides (e.g., peptide frag-
ments derived from the digestion of casein or albu-
min, gastrointestinal regulatory peptides, somatosta-
tin, calcitonin, gonadotropin-releasing hormone,
thyrotropin-releasing hormone), growth factors, en-
zymes, steroids, prostaglandins, and immunoglobu-
lins [21^25]. A number of studies indicate that
some of these substances are biologically active in
neonates. We demonstrated here that apelin was
quite abundantly secreted in colostrum and milk.
When we examined the e¡ects of apelin-36 and
[pGlu]apelin-13 on cytokine production from mouse
spleen cells in response to CD3 cross-linking in an in
vitro culture, the productions of IFN-Q, IL-2, and IL-
4 were partially suppressed by these peptides, sug-
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gesting that apelin plays a role in regulating immune
responses. The question of whether or not mononu-
clear cells express APJ remains controversial : one
report has indicated that APJ mRNA could be in-
duced in human peripheral blood mononuclear cells
by stimulation with IL-2 and phytohemagglutinin
[9] ; another has reported that APJ mRNA was un-
detectable in these cells even after similar stimulation
[12], although APJ transcripts were detected in a
particular T cell line. We think that apelin would
act on mouse spleen cells via APJ expressed in a
certain subpopulation of T cells, although further
studies will be needed to con¢rm this hypothesis.
Transforming growth factor-L ordinarily suppresses
immune responses including cytokine production,
but it might act to enhance innate immunity if ad-
ministered orally [26]. We therefore think that apelin
secreted in milk might work to the advantage of neo-
nates by helping them survive through the modula-
tion of immune responses.
Apelin has unique characteristics, such as exoge-
nous secretion and a diverse molecular heterogeneity.
We believe that further studies on apelin will provide
new insights into unknown physiological regulatory
mechanisms and the vital function of the colostrum
and milk.
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